跳至主要内容
临床试验/NCT04928664
NCT04928664已完成4 期

Continuous Standard Bupivacaine Versus Single Liposomal Bupivacaine Injection for Interscalene Brachial Plexus Block for Pain Management After Proximal Humerus Fracture Fixation

The University of Hong Kong2 个研究点 分布在 1 个国家目标入组 78 人开始时间: 2020年9月9日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
78
试验地点
2
主要终点
Weighted area under curve (AUC) pain score at rest

研究概览

简要总结

Restricted range of shoulder motion following ORIF is a potential complication that severely affects the patients' functional outcome and should be actively avoided by means of adequate pain control in addition to early mobilization and physiotherapy.

Peripheral nerve blocks, which can be given as a single injection or continuous infusion via an indwelling catheter, are analgesic options to be considered. Interscalene Block (ISB) is the regional analgesia of choice for the shoulder and proximal humerus region. While continuous infusion (aka continuous nerve block) offers the advantage of a longer duration of analgesia compared to a single injection of standard local anaesthetic, it is associated with an inherent risk of catheter displacement, dislodgement, obstruction, and infection.

Compared to Standard Bupivacaine (SB), Liposomal Bupivacaine (LB) is a formulation designed to prolong the duration of action to up to 72 hours by slow release of bupivacaine from the multi-vesicular liposomes. Several studies have demonstrated satisfactory analgesic effects of liposomal bupivacaine given as local surgical site infiltration over placebo. However, the effects of single injection of liposomal bupivacaine given via local surgical site infiltration compared to continuous nerve block have been inconsistent. Administrating liposomal bupivacaine directly to peripheral nerve blocks is a potentially effective approach that has not been extensively studied. ISB with single shot liposomal bupivacaine has been shown to provide superior postoperative analgesia compared to ISB with injection of standard bupivacaine or placebo. ISB with liposomal bupivacaine could perhaps prolong and improve postoperative analgesia without the potential problems with continuous nerve blocks. The analgesic effect of ISB with single shot liposomal bupivacaine versus continuous ISB with standard bupivacaine has not been previously investigated. The aim of this study is to compare the analgesic effect of these two analgesic modalities for plate fixation of proximal humerus fractures.

详细描述

CONDUCT OF ISB:

Side effects and potential complications will be explained and informed consent will be obtained from all subjects.

Time-out will be performed before the start of ISB in accordance with the WHO checklist, confirming the side of surgery with the subject.

Standard monitoring will be placed and an intravenous catheter will be established.

All ISB will be performed by anaesthetists experienced in ultrasound-guided ISB.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

盲法说明

The subjects, the investigators, and all the parties involved in patient management or data collection will be blinded throughout the study period.

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •ASA I-III
  • •Age between 18 and 80
  • •Proximal humeral fracture

排除标准

  • •Surgical exclusion criteria:
  • •Revision surgery
  • •Pathological fracture
  • •4-part or shaft fracture
  • •Multiple fractures
  • •Unable to attend rehabilitation
  • •Preexisting shoulder problems
  • •Abbreviated Mental Test Score (AMT score) < 8
  • •Allergy to amide local anaesthetics, paracetamol, non-steroidal anti-inflammatory drugs (NSAIDS), opioids
  • •Respiratory Disease with limited respiratory reserve
  • •Cardiac Disease: Any degree of Heart Block, Heart Failure
  • •Neurological: Any Seizure Disorder
  • •Psychiatric illnesses affecting pain perception e.g. severe depression and anxiety disorder
  • •Alcohol or substance abuse
  • •Chronic Pain, other than chronic knee pain
  • •Daily use of strong opioids (morphine, fentanyl, hydromorphone, ketobemidone, methadone, diamorphine, oxycodone, or meperidine) before operation
  • •Impaired Renal Function (defined as preoperative eGFR < 30ml /min /1.73 m2)
  • •Impaired Hepatic Function
  • •Pregnancy
  • •Inability to use PCA
  • •Patient refusal to ISB
  • •Patient refusal to study

研究组 & 干预措施

Liposoaml Bupivacaine (LB) Group

Active Comparator

Intervention group

干预措施: Liposomal bupivacaine (Drug)

Standard Bupivacaine (SB) Group

Experimental

Control group

干预措施: Standard bupivacaine (Drug)

结局指标

主要结局

Weighted area under curve (AUC) pain score at rest

时间窗: 0-48 hours after surgery

Pain severity would be rated at rest after surgery using numerical rating scale (NRS) with 0 to 10 where 0=no pain and 10=the worst possible pain

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Dr. Chan Chi-Wing

Honorary Clinical Associate Professor

The University of Hong Kong

研究点 (2)

Loading locations...

相似试验